These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38466855)

  • 1. Intergenomic signatures of coevolution between Tasmanian devils and an infectious cancer.
    Gallinson DG; Kozakiewicz CP; Rautsaw RM; Beer MA; Ruiz-Aravena M; Comte S; Hamilton DG; Kerlin DH; McCallum HI; Hamede R; Jones ME; Storfer A; McMinds R; Margres MJ
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2307780121. PubMed ID: 38466855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils.
    Raven N; Klaassen M; Madsen T; Jones M; Hamilton DG; Ruiz-Aravena M; Thomas F; Hamede RK; Ujvari B
    Front Immunol; 2024; 15():1286352. PubMed ID: 38515744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial variation in gene expression of Tasmanian devil facial tumors despite minimal host transcriptomic response to infection.
    Kozakiewicz CP; Fraik AK; Patton AH; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Hohenlohe PA; Margres MJ; Jones ME; Storfer A
    BMC Genomics; 2021 Sep; 22(1):698. PubMed ID: 34579650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association.
    Wright B; Willet CE; Hamede R; Jones M; Belov K; Wade CM
    Sci Rep; 2017 Mar; 7(1):423. PubMed ID: 28341828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
    Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
    Hubert JN; Zerjal T; Hospital F
    PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary and historical selection in Tasmanian devils (
    Stahlke AR; Epstein B; Barbosa S; Margres MJ; Patton AH; Hendricks SA; Veillet A; Fraik AK; Schönfeld B; McCallum HI; Hamede R; Jones ME; Storfer A; Hohenlohe PA
    Proc Biol Sci; 2021 May; 288(1951):20210577. PubMed ID: 34034517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative landscape genetics reveals differential effects of environment on host and pathogen genetic structure in Tasmanian devils (Sarcophilus harrisii) and their transmissible tumour.
    Kozakiewicz CP; Ricci L; Patton AH; Stahlke AR; Hendricks SA; Margres MJ; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Jones ME; Hohenlohe PA; Storfer A
    Mol Ecol; 2020 Sep; 29(17):3217-3233. PubMed ID: 32682353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.
    Pye R; Patchett A; McLennan E; Thomson R; Carver S; Fox S; Pemberton D; Kreiss A; Baz Morelli A; Silva A; Pearse MJ; Corcoran LM; Belov K; Hogg CJ; Woods GM; Lyons AB
    Front Immunol; 2018; 9():259. PubMed ID: 29515577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
    Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM
    Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission.
    Cui X; Wang Y; Hua B; Miller W; Zhao Y; Cui H; Kong X
    Biochem Biophys Res Commun; 2016 May; 474(1):29-34. PubMed ID: 27084454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious disease and sickness behaviour: tumour progression affects interaction patterns and social network structure in wild Tasmanian devils.
    Hamilton DG; Jones ME; Cameron EZ; Kerlin DH; McCallum H; Storfer A; Hohenlohe PA; Hamede RK
    Proc Biol Sci; 2020 Dec; 287(1940):20202454. PubMed ID: 33290679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserving adaptive potential: lessons from Tasmanian devils and their transmissible cancer.
    Hohenlohe PA; McCallum HI; Jones ME; Lawrance MF; Hamede RK; Storfer A
    Conserv Genet; 2019 Feb; 20(1):81-87. PubMed ID: 31551664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils.
    Peck S; Corkrey R; Hamede R; Jones M; Canfield P
    Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.